baber/WOPTO huggingface dataset:
Patent DE-69511480-D1 (DE)
Inventor: STOKLEY HENRY WALKER
IPC: B65D81/24
Filed: 1995-06-28
Granted: 1999-09-23
Abstract: A package comprising a product support member (12), an oxygen-permeable film (14) over the product support member, and an oxygen-impermeable film (16) over the oxygen-permeable film and in close proximity thereto, has an oxygen-permeable region (18) between the oxygen-permeable and impermeable films, and the oxygen-impermeable film bounds at least a portion of a confined volume (15) comprising an amount of gaseous oxygen effective to inhibit discoloration of the product (10). <MATH>
Patent DE-69524604-D1 (DE)
Inventor: LUK SYDNEY
IPC: C10M103/06
Filed: 1995-08-09
Granted: 2002-01-24
Abstract: The present invention provides lubricant compositions for the powder metallurgical field. The lubricant compositions contain a solid phase lubricant such as graphite, molybdenum disulfide, and polytetrafluoroethylene in combination with a liquid phase lubricant that is a binder for the solid phase lubricant. The binder can be chosen from various classes of compounds including polyethylene glycols, polyethylene glycol esters, partial esters of C3-6 polyhydric alcohols, polyvinyl esters, and polyvinyl pyrrolidones. The binder is solubilized in an organic solvent.
Patent DE-69604924-D1 (DE)
Inventor: GREEN FREDERICK
IPC: C22B3/00
Filed: 1996-08-14
Granted: 1999-12-02
Abstract: The present invention relates to improved methods for the extraction and/or recovery of elements, more preferably metals, from starting materials such as mineral ores, recyclable wastes, contaminated soils, toxic wastes such as dusts producing through steelmaking processes (such as electric arc furnace dusts and BOP dusts), and other materials. More particularly, the present invention relates to methods involving a chemical processing step in which the starting materials are contacted with a caustic silica solution.
Patent DE-69606274-D1 (DE)
Inventor: SHEPPERD III PAUL W
IPC: C02F1/70
Filed: 1996-12-10
Granted: 2000-02-24
Abstract: Liq. effluent contg. dye(s) is treated as follows: (a) a reducing agent (I) is added at 50-100 ppm/1000 ADMI units of colour; (b) the effluent pH is reduced to 2-7; (c) a charge neutralisation mixt. comprising (i) 1 or more Al salts (II), and (ii) a cationic polymer (III) in wt. ratio 30-70:70-30 is added until the Zeta potential reaches +/-15 m volts; (d) the pH is adjusted to at least 5; and (e) the mixt. is flocculated by addn. of 1-5 ppm of a flocculant (IV). (II) is Al (poly)hydroxy-chloride, alum, AlCl3 and NaAlO2. (III) are (i) 1 or more H2O-soluble copolymer(s) of acrylamide with (meth)acryloylethyl tri-Me NH4 (X-) (X = Cl, Br, I, SO4, and MeSO4); (ii) cpds. of formula (III)(ii) below; and (iii) cpds. of formula (III)(iii) below. (IV) are (i) anionic acrylic acid/acrylamide copolymers of mol. wt. above 2,000,000, and/or (ii) nonionic polyacrylamides of mol. wt. above 2,000,000. H-[N+ (X-)(R1)(R2)-CH2CH(OH)CH2]m-H (III)(ii) R1, R2 = H or 1-8C opt. branched, opt. substd. alkyl; X- = Cl, Br, I, SO4, and MeSO4; m = 200-50,000; R3, R4 = 1-8C opt. branched alkyl.
Patent DE-69616993-D1 (DE)
Inventor: NUSSBAUMER PETER
IPC: C07D239/74
Filed: 1996-03-14
Granted: 2001-12-20
Abstract: PCT No. PCT/EP96/01116 Sec. 371 Date Sep. 15, 1997 Sec. 102(e) Date Sep. 15, 1997 PCT Filed Mar. 14, 1996 PCT Pub. No. WO96/28430 PCT Pub. Date Sep. 19, 1996The invention concerns compounds of formula I wherein the substituents have various meanings, and their use in the prevention or treatment of inflammatory and proliferative skin diseases and cancer.
Patent DE-69621887-D1 (DE)
Inventor: BAGGEN PAUL
IPC: H03M13/27
Filed: 1996-01-26
Granted: 2002-07-25
Abstract: Data is transmitted with a signal containing a number of simultaneously active modulated frequency channels. The data may be encoded in an error protecting code. Successive data items are mapped pseudo-randomly to different frequency channels. This protects against fading which affects frequency channels that are located at periodic distances from each other. The pseudo random mapping is realized by writing the data-items into memory in one order and reading them from memory in another order. Successive signals are each modulated in this way. The memory locations vacated upon reading for the modulation of one signal are filled by data-items for modulating the next successive signal. This is kept up by permuting the order of the memory locations in which the data-items are written for each successive signal.
Patent DE-69622179-D1 (DE)
Inventor: ZETTERGREN LEIF GOESTA
IPC: H05B6/76
Filed: 1996-09-20
Granted: 2002-08-08
Abstract: Method of shielding against microwaves for mobile microwave appliances open at the bottom. The radiation path through the small gap between the equipment casing and the surface underneath is lengthened by edge widening. Microwave appliance to be used at the method.
Patent DE-69626842-D1 (DE)
Inventor: BOESTEN HUBERTUS
IPC: C07D501/12
Filed: 1996-12-06
Granted: 2003-04-24
Abstract: The invention relates to a process for the preparation of an antibiotic, in particular cefalexin, ampicillin, amoxicillin, cefaclor, cefradin, cefadroxil, cefotaxim and the like, wherein a beta-lactam core is acylated, the antibiotic is recovered from the reaction mixture, the remaining mother liquor is subjected to a hydrolysis reaction in which the antibiotic present in the mother liquor is decomposed into its initial compounds, in particular the beta-lactam core, and the acylation agent is hydrolized. The beta-lactam core can then be recovered virtually quantitatively or recycled to the acylation reaction. This is because it has been found that the solubility of the beta-lactam core is unexpectedly high at relatively high concentrations of acylation agent and antibiotic.
Patent DE-69631372-D1 (DE)
Inventor: THOMAS GERARD
IPC: H04Q7/20
Filed: 1996-10-07
Granted: 2004-02-26
Abstract: The system includes a central communication equipment (4) fitted with some first transceiving devices (5,6) connected to at least one radio transmit and receive cable (3) servicing the entire installation. It also includes some subscriber's appliances (2A to 2E) located within the installation and is fitted with second transceiving devices (8 to 12) which transmit and/or receive radio signals, allowing these appliances to communicate via the communications equipment. The communications equipment ensures forwarding of the signals it receives to each destination appliance within the installation and, with the help of gateway devices (27 to 31), outside the installation..
Patent DE-69637315-D1 (DE)
Inventor: NEUSCHAEFER DIETER
IPC: G01N21/77
Filed: 1996-05-02
Granted: 2007-12-20
Abstract: The invention relates to a sensor platform based on at least two planar, separate, inorganic dielectric waveguiding regions on a common substrate and to an apparatus for the parallel evanescent excitation and detection of the luminescence of identical or different analytes. The invention relates also to a sensor platform having the planar, separate, inorganic dielectric waveguiding regions and one or more organic phases immobilised thereon. A further subject of the invention is the use of the sensor platform in a luminescence detection method for quantitative affinity sensing and for the selective quantitative determination of luminescent constituents of optically opaque solutions.
Patent DE-69637389-D1 (DE)
Inventor: KUTYAVIN IGOR V
IPC: C12Q1/68
Filed: 1996-04-03
Granted: 2008-02-14
Abstract: Conjugates between a minor groove binding molecule, such as the trimer of 1,2-dihydro-(3H)-pyrrolo[3,2-e]indole-7-carboxylate (CDPI3), and an oligonucleotide form unusually stable hybrids with complementary target sequences, in which the tethered CDPI3 group resides in the minor groove of the duplex. These conjugates can be used as probes and primers. Due to their unusually high binding affinity, conjugates as short as 8-mers can be used as amplification primers with high specificity and efficiency. MGB conjugation also increases the discriminatory power of short oligonucleotides, providing enhanced detection of nucleotide sequence mismatches by short oligonucleotides. The MGB-conjugated probes and primers described herein facilitate various analytic and diagnostic procedures, such as amplification reactions, PCR, detection of single-nucleotide polymorphisms, gene hunting, differential display, fluorescence energy transfer, hydrolyzable probe assays and others; by allowing the use of shorter oligonucleotides, which have higher specificity and better discriminatory power.
Patent DE-69706776-D1 (DE)
Inventor: SCHAPIRA JOSEPH
IPC: A01N37/40
Filed: 1997-07-04
Granted: 2001-10-25
Abstract: A food-grade bactericidal composition comprises (a) a monoester of a C10 or C12 saturated fatty acid and glycerol together with (b) an alkyl ester of p-hydroxybenzoic acid and (c) an effective amount of n-propyl gallate. Preferred compositions comprise 5-70 (preferably 8-60) % (c), 0.05-50 (preferably 0.1 - 47) % (a) and 5-95 (preferably 7-91) % (b). The compositions are preferably used in the form of solutions in water/ethanol, water/isopropanol, water/n-propanol or propylene glycol. (a) is preferably monocaprin or monolaurin. (b) is preferably the ethyl- or n-propyl ester of p-hydroxybenzoic acid.
Patent DE-69708929-D1 (DE)
Inventor: NARUMI KENJI
IPC: G11B7/00
Filed: 1997-06-02
Granted: 2002-01-17
Abstract: An apparatus for writing on and reading an overwritable optical disk comprises an identifier detector (119) that identifies a recording condition in the sector to be overwritten, and a delay time controller circuit (106) that sets a variation range of the start point for writing according to the recording condition. The record timing of the modulated data signal (105) is changed at random within the set variation range when overwriting the sector of the optical disk (113). <IMAGE>
Patent DE-69718460-D1 (DE)
Inventor: VAN VLIET ADRIANUS
IPC: H01J61/20
Filed: 1997-10-20
Granted: 2003-02-20
Abstract: Metal halide lamp with ceramic discharge vessel having electrodes with spacing EA, internal diameter Di, and EA/Di>5. Ionizable filling comprises NaI and CeI3, and a coldest spot temperature of 1100-1500 K is achieved.
Patent DE-69720773-D1 (DE)
Inventor: PRUITT JAMES RUSSELL
IPC: C07D263/34
Filed: 1997-12-18
Granted: 2003-05-15
Abstract: The present application describes oxygen and sulfur containing heteroaromatics and derivatives thereof of formula (I), or pharmaceutically acceptable salt or prodrug forms thereof, wherein J is O or S and D may be C(=NH)NH2, which are useful as inhibitors of factor Xa.                              00000
Patent DE-69724418-D1 (DE)
Inventor: JEPPESEN LONE
IPC: A61P43/00
Filed: 1997-04-02
Granted: 2003-10-02
Abstract: The present invention relates to therapeutically active azatricyclic compounds of formula I a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in treating a disease in the central nervous system caused by malfunctioning of the muscarinic cholinergic system.
Patent DE-69727376-D1 (DE)
Inventor: KULAWIEC W
IPC: G01B11/30
Filed: 1997-05-30
Granted: 2004-03-04
Abstract: Thickness variations of semiconductor wafers are measured by interfering two beams of infrared light that are relatively modified by reflections from opposite side surfaces of the wafers. Non-null interferometric measurements are made by illuminating the wafers with diverging beams and subtracting errors caused by varying angles of incidence. Null interferometric measurements are made of both thickness variations and flatness. Infrared light, which can transmit through the wafers, is used for measuring thickness variations; and visible light, which cannot transmit through the wafers, is used for simultaneously measuring flatness.
Patent DE-69729312-D1 (DE)
Inventor: HENNINK EVERHARDUS
IPC: A61K9/20
Filed: 1997-11-17
Granted: 2004-07-01
Abstract: The present invention relates to a process for the preparation of a system having good controlled release behaviour. It comprises two water-soluble polymers and a proteinaceous material. <??>An aqueous two-phase system is formed, wherein the proteinaceous material is comprised in the dispersed phase. The dispersed phase is cross linked.
Patent DE-69731072-D1 (DE)
Inventor: WOO SOO
IPC: A61K47/10
Filed: 1997-06-19
Granted: 2004-11-11
Abstract: A composition (A) comprises: (a) cyclosporin (I) as active ingredient; (b) polyethylene glycol (PEG) and/or propylene carbonate (PC); (c) an oil component consisting of a mixture of an esterified compound of fatty acid and primary alcohol, and fatty acid monoglyceride; and (d) a surfactant (HLB value 8-17). Also claimed is the preparation of the composition comprising: (i) mixing (b), (c) and (d); (ii) adding (a) with stirring and heating to 60[deg]C; and optionally (iii) encapsulating the concentrate into a gelatin shell soft capsule containing PEG and propylene glycol as the plasticiser, followed by air cooling.
Patent DE-69732641-D1 (DE)
Inventor: ITO SADAKUNI
IPC: G10K11/175
Filed: 1997-10-08
Granted: 2005-04-07
Abstract: A muffling wall of a new-type lightweight construction having a function of effectively isolating sounds in low and medium sound range and high muffling characteristics in a relatively low frequency band area, and comprising at least two facing diaphragms, a frame body for fixing of the diaphragms, and a mechanical type opposite phase vibration transmitting mechanism for connection of the diaphragms. The vibration transmitting mechanism mechanically converts vibration of one of the diaphgrams, which receives sounds to vibrate, into opposite phase vibrations to transmit the same to the other of the diaphragms such that vibrational energy of the original sound causes the other of the diaphragms to displace inward or outward and vibrate simultaneously with one of the diaphragms. <IMAGE>
Patent DE-69733868-D1 (DE)
Inventor: KUMP JOHN
IPC: G02F1/29
Filed: 1997-09-06
Granted: 2005-09-08
Abstract: The optical system (20) includes an acoustooptic device (23) with a drive electrode (24), an acoustic transducer (18), and a transparent optical medium (19) with an aperture (17). A radio-frequency (RF) drive power generator (28) supplies RF drive power at a drive carrier frequency. An RF modulator (25) is connected to the RF drive power generator and a modulating signal source (26). The RF modulator supplies modulated RF drive power modulated with the modulating signal. An RF power compensator supplies RF compensating power at frequencies different from the drive carrier frequency. The RF compensating power complements the modulated RF drive power. The modulated RF drive power and the RF compensating power are combined. A driver is connected to the combiner and the drive electrode for powering the acoustooptic device with the combination of the modulated RF drive power and the RF compensating power such that the spatial thermal energy distribution inside the acoustooptic device remains constant.
Patent DE-69735757-D1 (DE)
Inventor: KLODT UTE
IPC: A61F13/534
Filed: 1997-06-25
Granted: 2006-06-01
Abstract: The present invention relates to non-unitary absorbent articles which comprise at least two elements, whereby the element positioned towards the wearer has a higher ultimate storage capacity than the outer one, and further providing a superior skin dryness performance.   <IMAGE>
Patent DE-69735851-D1 (DE)
Inventor: KOEZUKA YASUHIKO
IPC: A61K35/51
Filed: 1997-12-25
Granted: 2006-06-14
Abstract: A method for activating human antigen presenting cells characterized by culturing in vitro antigen presenting cells with a human origin together with at least one of glycoside compounds represented by general formula (A) or salts thereof preferably exemplified by (2S, 3S, 4R)-1-( alpha -D-galactopyranosyloxy)-2-hexacosanoylamino-3,4-octadecanediol; the human antigen presenting cells thus activated; methods for treating cancer or infectious diseases such as AIDS by using activated human antigen presenting cells; and the use of activated human antigen presenting cells in the production of drugs for treating these diseases. Thus, sufficient therapeutic effects can be achieved on cancer and infectious diseases such as AIDS without effecting any pulse therapy with the use of tumor antigens. <CHEM>
Patent DE-69808426-D1 (DE)
Inventor: MURRAY A
IPC: E04C2/52
Filed: 1998-01-15
Granted: 2002-11-07
Abstract: Communications cable is routed within horizontal pathways between the structural ceiling and drop ceiling to a fire-resistant cabinet mounted between the ceilings. Communication cable switching and termination equipment is carried by the cabinet for providing a consolidation point and cross-connect location for both copper wire and optical fiber cables serving work stations within an open office architecture. The cabinet includes an access door opening into a room below the drop ceiling for providing user access to the equipment. The door lies within the drop ceiling plane when in the closed position. A removable equipment mounting plate is carried by the cabinet for lowering the equipment below the drop ceiling when the door is in the open position. Cabinet fire-resistant side wall penetrations permits the communications cable routed between the ceilings to enter and exit the cabinet for connection with the communications cable switching and termination equipment. With the use of the cabinet, the amount of communication cable required to service work stations in an open office architecture is greatly reduced.
Patent DE-69812408-D1 (DE)
Inventor: MINOTTI PATRICE
IPC: A61M25/00
Filed: 1998-12-03
Granted: 2003-04-24
Abstract: An electrostatic microactuator, known as a "Scratch Drive Actuator" or SDA, is based on a collective set of distributed elementary SDAs of small size that are associated with one another and that integrates a large number so as to allow the addition of the forces generated by each of the SDAs in the collective set. An external mechanical prestress, formed by a homogeneous external pressure in the form of a bias voltage applied at rest to the associated SDAs, is applied to the SDAs to allow a superposition of the forces generated by the associated SDAs. This is done while communicating to an external load the entire driving force emanating from the collective behavior of the SDAs. The electrostatic attraction forces established by the bias voltage are used to calibrate an individualized prestress for each actuator involved in the collective set. Such an electrostatic microactuator forms part of an active three-dimensional microcatheter, as one possible application, that can be used in a blood vessel.
Patent DE-69821366-D1 (DE)
Inventor: XU XIAOYING
IPC: H02G15/08
Filed: 1998-08-21
Granted: 2004-03-04
Abstract: The invention provides a plug-in type connector of the three-phase electrical cable, comprising head body of at least two plug-in sockets, and plug-in contact portion corresponding to amount of said plug-in socket, outside of head body and plug-in contact portion being insulative. There are three intermediate conductors arranged within the head body, and each plug-in contact socket on the head body has three plug-in holes isolated by insulating layer and corresponding to three intermediate conductors respectively, and inner terminal of each plug-in hole has connecting socket connected with same phase intermediate conductor, said connecting socket has axial lock means. Plug-in contact portion has three conducting rods and three electric connecting means, and also has wire support sleeve for separating three wire cores of electrical cable. After inserting three conducting rods into plug-in holes, axial lock means within head body will lock it up. Shield layers are arranged within insulator of head and plug-in contact portion respectively for the each phase transmission path. <IMAGE>
Patent DE-69822870-D1 (DE)
Inventor: HENGEVELD E
IPC: A61P31/04
Filed: 1998-11-17
Granted: 2004-05-06
Abstract: Disclosed is an improved and efficient process for N-desmethylating the 3'-amino nitrogen of erythromycins and for converting the 3'-N-desmethylated erythromycins into 3'-N-substituted derivatives of 8,9-anhydro-erythromycin 6,9-hemiketals.
Patent DE-69827805-D1 (DE)
Inventor: NOTEBORN HUBERTUS
IPC: G01N33/15
Filed: 1998-08-11
Granted: 2004-12-30
Abstract: The invention related to activation of apoptin-induced apoptosis by different cell-transforming agents in normal and or cancer-prone cells. Apoptin, also called VP3, is a viral protein derived from the Chicken anemia virus. Also the invention related to preventive anti-tumor therapies of normal and/or cancer-prone cells. Treatment of normal and/or cancer prone cells with tumor-inducing agents will activate apoptin-induced apoptosis, resulting in the elimination of potential tumor cells. Also the invention relates to diagnosis of cancer agents. Agents with tumor activity can be examined by expressing them in normal cells and analyzing their capability of enabling apoptin-induced apoptosis.
Patent DE-69829107-D1 (DE)
Inventor: GARD MICHAEL
IPC: E21B47/09
Filed: 1998-12-29
Granted: 2005-03-31
Abstract: A system and method use magnetic field sensing to detect underground objects for strike avoidance. The system detects magnetic field components for both passive distortions in the magnetic field indicative of a ferromagnetic object and active magnetic fields that are impressed on an object by a signal generator. A detection module has a magnetic sensor assembly that detects the magnetic field components. The magnetic field component data is transferred through a multiplexer to an analog/digital converter to a processor. Pitch angle data from a pitch sensor and roll angle data from a roll sensor also may be transferred to the processor. The data is processed by the processor to determine the orientation of the detection module with respect to the object. The detection module may be installed in an underground boring tool or a trenching assembly. <IMAGE>
Patent DE-69833191-D1 (DE)
Inventor: SHULZE E
IPC: G01L9/04
Filed: 1998-04-16
Granted: 2006-04-06
Abstract: A physiological pressure transducer is disclosed which can be adapted for multiple uses and which employs a low cost semiconductor strain gauge sensor. The transducer is connected to a fluid-filled catheter/manometer system for measuring pressures inside a living body in areas of medical interest such as the heart, brain, uterus, or the vascular system. The catheter is coupled to the pressure transducer through a unique, disposable dome containing a shaped, compliant isolation media which is in intimate contact with the transducer diaphragm. The complete assembly is adapted for use with standard catheter flushing solutions and flush devices. An improved method of drawing blood samples by using the features of the assembly is also described.
Patent DE-69834712-D1 (DE)
Inventor: CLARK B
IPC: G07F7/10
Filed: 1998-03-13
Granted: 2006-07-06
Abstract: An encryption module for encrypting financial and other sensitive data may be conveniently interposed in series between a personal computer and the keyboard associated therewith. An application program designed to run on the PC is configured to prompt the user to enter his PIN or other confidential data into the encryption module; consequently the confidential data need not be transmitted in an unencrypted fashion, and need not reside on the PC hard drive in an unencrypted form.
Patent DE-69838804-D1 (DE)
Inventor: RINNE GLENN A
IPC: C25D7/12
Filed: 1998-04-28
Granted: 2008-01-17
Abstract: A method of electroplating solder bumps on an integrated circuit substrate containing a plurality of active semiconductor devices in the substrate and a plurality of contact pads electrically connected to the active semiconductor devices, comprising the steps of: 
forming a plating base layer which electrically shorts the plurality of contact pads together, on the substrate; and 
electroplating solder bumps on the plating base layer by drawing plating current vertically through the substrate via a first plurality of parallel electrical paths formed by the plating base layer and the plurality of active semiconductor devices.